Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2023-05-22 00:00:00 ET · period of report 2023-05-18 · accession 0001162194-23-000030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-22 | 2023-05-18+ | LAB | Black Jeffrey G. | SVP, CFO | P - Purchase | $2.25 | +86.0K | 43.5K | New | +$193.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-19 | P | A | 42,492 | $2.29 | 85,984 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $2.23 to $2.32. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| 2 | Common | Common Stock | 2023-05-18 | P | A | 43,492 | $2.22 | 43,492 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $2.14 to $2.28. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |